Literature DB >> 17342490

Biopsy standards for detection of prostate cancer.

Bob Djavan1, Markus Margreiter.   

Abstract

The widespread use of measurement of prostate-specific antigen for prostate cancer screening has led to a dramatic increase in the number of transrectal biopsies. Although transrectal ultrasound-guided prostate biopsy is the gold standard in the diagnosis of prostate cancer, the strategies for initial and repeat biopsies remain controversial. Over the past decade numerous biopsy protocols have been developed. Several protocols have been established that increase the number of cores by combining sextant and lateral biopsies to increase the cancer detection rate. We review the current methods of prostate biopsies, the indication to perform an initial and repeat biopsy, the impact of prostate volume on the number of cores taken, and the morbidity of the procedure.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17342490     DOI: 10.1007/s00345-007-0151-1

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  47 in total

1.  The problem of infection after prostatic biopsy: the case for the transperineal approach.

Authors:  P M Thompson; J P Pryor; J P Williams; D E Eyers; C Dulake; M F Scully; V V Kakkar
Journal:  Br J Urol       Date:  1982-12

2.  Diagnostic value of ten systematic TRUS-guided prostate biopsies.

Authors:  V Ravery; T Billebaud; M Toublanc; L Boccon-Gibod; J F Hermieu; F Moulinier; E Blanc; V Delmas; L Boccon-Gibod
Journal:  Eur Urol       Date:  1999-04       Impact factor: 20.096

3.  Observations on pathology trends in 62,537 prostate biopsies obtained from urology private practices in the United States.

Authors:  R Orozco; G O'Dowd; B Kunnel; M C Miller; R W Veltri
Journal:  Urology       Date:  1998-02       Impact factor: 2.649

4.  Prostatic intraepithelial neoplasia: influence of clinical and pathological data on the detection of prostate cancer.

Authors:  G Raviv; T Janssen; A R Zlotta; F Descamps; A Verhest; C C Schulman
Journal:  J Urol       Date:  1996-09       Impact factor: 7.450

5.  Patient tolerance of transrectal ultrasound-guided biopsy of the prostate.

Authors:  J Irani; F Fournier; D Bon; E Gremmo; B Doré; J Aubert
Journal:  Br J Urol       Date:  1997-04

6.  Use of repeat sextant and transition zone biopsies for assessing extent of prostate cancer.

Authors:  J I Epstein; P C Walsh; J Sauvageot; H B Carter
Journal:  J Urol       Date:  1997-11       Impact factor: 7.450

7.  The sextant protocol for ultrasound-guided core biopsies of the prostate underestimates the presence of cancer.

Authors:  M Norberg; L Egevad; L Holmberg; P Sparén; B J Norlén; C Busch
Journal:  Urology       Date:  1997-10       Impact factor: 2.649

8.  Do prostate specific antigen and prostate specific antigen density enhance the detection of prostate carcinoma after initial diagnosis of prostatic intraepithelial neoplasia without concurrent carcinoma?

Authors:  G Raviv; A R Zlotta; T h Janssen; F Descamps; J P Vanegas; A Verhest; C C Schulman
Journal:  Cancer       Date:  1996-05-15       Impact factor: 6.860

9.  Optimization of prostate biopsy strategy using computer based analysis.

Authors:  M E Chen; P Troncoso; D A Johnston; K Tang; R J Babaian
Journal:  J Urol       Date:  1997-12       Impact factor: 7.450

10.  Prospective evaluation of lateral biopsies of the peripheral zone for prostate cancer detection.

Authors:  J J Chang; K Shinohara; V Bhargava; J C Presti
Journal:  J Urol       Date:  1998-12       Impact factor: 7.450

View more
  20 in total

Review 1.  [Multiparametric MRI, elastography, contrastenhanced TRUS. Are there indications with reliable diagnostic advantages before prostate biopsy?].

Authors:  A Hegele; L Skrobek; R Hofmann; P Olbert
Journal:  Urologe A       Date:  2012-09       Impact factor: 0.639

2.  Simulation optimization of PSA-threshold based prostate cancer screening policies.

Authors:  Daniel J Underwood; Jingyu Zhang; Brian T Denton; Nilay D Shah; Brant A Inman
Journal:  Health Care Manag Sci       Date:  2012-12

3.  An MRI-compatible robotic system with hybrid tracking for MRI-guided prostate intervention.

Authors:  Axel Krieger; Iulian I Iordachita; Peter Guion; Anurag K Singh; Aradhana Kaushal; Cynthia Ménard; Peter A Pinto; Kevin Camphausen; Gabor Fichtinger; Louis L Whitcomb
Journal:  IEEE Trans Biomed Eng       Date:  2011-11       Impact factor: 4.538

Review 4.  Advances in medical imaging for the diagnosis and management of common genitourinary cancers.

Authors:  Mohammad H Bagheri; Mark A Ahlman; Liza Lindenberg; Baris Turkbey; Jeffrey Lin; Ali Cahid Civelek; Ashkan A Malayeri; Piyush K Agarwal; Peter L Choyke; Les R Folio; Andrea B Apolo
Journal:  Urol Oncol       Date:  2017-05-12       Impact factor: 3.498

5.  Endorectal multiparametric 3-tesla magnetic resonance imaging associated with systematic cognitive biopsies does not increase prostate cancer detection rate: a randomized prospective trial.

Authors:  Gianluigi Taverna; Giorgio Bozzini; Fabio Grizzi; Mauro Seveso; Alberto Mandressi; Luca Balzarini; Federica Mrakic; Pietro Bono; Oliviero De Franceco; NicolòMaria Buffi; Giovanni Lughezzani; Massimo Lazzeri; Paolo Casale; Giorgio Ferruccio Guazzoni
Journal:  World J Urol       Date:  2015-10-19       Impact factor: 4.226

Review 6.  The Current State of MR Imaging-targeted Biopsy Techniques for Detection of Prostate Cancer.

Authors:  Sadhna Verma; Peter L Choyke; Steven C Eberhardt; Aytekin Oto; Clare M Tempany; Baris Turkbey; Andrew B Rosenkrantz
Journal:  Radiology       Date:  2017-11       Impact factor: 11.105

7.  Development and Evaluation of an Actuated MRI-Compatible Robotic System for MRI-Guided Prostate Intervention.

Authors:  Axel Krieger; Sang-Eun Song; Nathan B Cho; Iulian Iordachita; Peter Guion; Gabor Fichtinger; Louis L Whitcomb
Journal:  IEEE ASME Trans Mechatron       Date:  2011-10-17       Impact factor: 5.303

8.  Applications of transrectal ultrasound in prostate cancer.

Authors:  C J Harvey; J Pilcher; J Richenberg; U Patel; F Frauscher
Journal:  Br J Radiol       Date:  2012-07-27       Impact factor: 3.039

9.  Transperineal prostate biopsy: analysis of a uniform core sampling pattern that yields data on tumor volume limits in negative biopsies.

Authors:  Gordon R Kepner; Jeremy V Kepner
Journal:  Theor Biol Med Model       Date:  2010-06-17       Impact factor: 2.432

10.  Development and validation of risk score for predicting positive repeat prostate biopsy in patients with a previous negative biopsy in a UK population.

Authors:  Mark A Rochester; Nora Pashayan; Fiona Matthews; Andrew Doble; John McLoughlin
Journal:  BMC Urol       Date:  2009-07-16       Impact factor: 2.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.